⌘K

Home/Filings/4/0001683168-17-002734

4//SEC Filing

Bamforth Mark R 4

Accession 0001683168-17-002734

CIK 0000704562other

View on SEC.gov Company Profile

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 5:22 PM ET

Size

5.5 KB

Accession

0001683168-17-002734

Insider Transaction Report

Form 4

Period: 2017-10-17

PEREGRINE PHARMACEUTICALS INCPPHM

Bamforth Mark R

Director

Transactions

Award
Stock Option (right to buy)
2017-10-17+75,000→ 75,000 total
Exercise: $3.88From: 2017-11-17Exp: 2027-10-17→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning November 17, 2017 and each month thereafter until fully-vested.

Documents

1 file

4
bamforth_frm4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PEREGRINE PHARMACEUTICALS INC

CIK 0000704562

Entity typeother

Related Parties

1

filerCIK 0001435745

Filing Metadata

Form type: 4
Filed: Oct 23, 8:00 PM ET
Accepted: Oct 24, 5:22 PM ET
Size: 5.5 KB

View on SEC.gov